Versigent

VGNT · NYSE

$43.87+$0.18 (+0.41%)TodayMarket closed · Oct 20, 6:30 PM ET

Prev close $43.69

Latest news

Press releaseOct 1, 7:05 AM ETBusiness Wire
Versigent Announces Third Quarter 2026 Earnings Call Details
NewsSep 28, 7:34 AM ET
Versigent Q2 2026 Earnings Call Transcript
Press releaseAug 26, 4:33 PM ETPRNewswire
Bloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution
NewsAug 19, 10:24 AM ETChris Katje
David Einhorn Has 7 New Stock Picks: Hedge Fund Manager Bets on Buyouts, Spinoffs
NewsAug 4, 6:56 AM ET
Versigent Q2 EPS $1.92 Beats $1.35 Estimate, Sales $2.444B Beat $2.313B Estimate
Press releaseAug 4, 6:45 AM ETBusiness Wire
Versigent Reports Second Quarter 2026 Results
Press releaseJul 15, 8:30 AM ETBusiness Wire
Versigent Announces Second Quarter 2026 Earnings Call
NewsJun 3, 1:25 PM ETPiero Cingari
S&P 500, Nasdaq 100 Drop From Records As Rate-Hike Bets Build, Oil Climbs: Stock Market Today
Press releaseMay 19, 9:00 AM ETBusiness Wire
Versigent Announces Participation in June Investor Conferences
Press releaseMay 5, 4:01 PM ETBusiness Wire
Versigent Reports First Quarter 2026 Results
NewsApr 24, 1:35 PM ET
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session
Press releaseApr 21, 2:03 PM ETBusiness Wire
Versigent Announces First Quarter 2026 Earnings Call and Participation in May Investor Conferences
NewsApr 9, 1:00 PM ETPiero Cingari
Oil Trim Gains, Stocks Rebound On Lebanon-Israel Talks: What's Moving Markets Thursday?
Press releaseApr 1, 8:55 AM ETPRNewswire
NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade
NewsApr 1, 8:02 AM ETAvi Kapoor
Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Press releaseApr 1, 12:01 AM ETBusiness Wire
Versigent Launches as New Publicly Traded Company
Press releaseMar 31, 4:30 PM ETBusiness Wire
Aptiv and Versigent to Release First Quarter 2026 Financial Results on May 5
Press releaseMar 30, 6:32 PM ETPRNewswire
Versigent Set to Join S&P SmallCap 600

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Versigent Announces Third Quarter 2026 Earnings Call Details

Versigent Q2 2026 Earnings Call Transcript

Bloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution

David Einhorn Has 7 New Stock Picks: Hedge Fund Manager Bets on Buyouts, Spinoffs

Versigent Q2 EPS $1.92 Beats $1.35 Estimate, Sales $2.444B Beat $2.313B Estimate

Versigent Reports Second Quarter 2026 Results

Versigent Announces Second Quarter 2026 Earnings Call

S&P 500, Nasdaq 100 Drop From Records As Rate-Hike Bets Build, Oil Climbs: Stock Market Today

Versigent Announces Participation in June Investor Conferences

Versigent Reports First Quarter 2026 Results

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

Versigent Announces First Quarter 2026 Earnings Call and Participation in May Investor Conferences

Oil Trim Gains, Stocks Rebound On Lebanon-Israel Talks: What's Moving Markets Thursday?

NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade

Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Versigent Launches as New Publicly Traded Company

Aptiv and Versigent to Release First Quarter 2026 Financial Results on May 5

Versigent Set to Join S&P SmallCap 600